F.M.J. Debruyne

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Marion J.G. Bussemakers, Adrie van Bokhoven, Gerald W. Verhaegh et al. · PubMed · 1999 · 1.1K citations

Medicine, Molecular Biology, Oncology +17

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology · 1992 · 795 citations

Medicine, Oncology, Urology +8

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study

Marloes van der Leest, Erik B. Cornel, Bas Israël et al. · European Urology · 2018 · 773 citations · Full text

Medicine, Radiology, Urology +17

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 330 citations

Medicine, Oncology, Pharmacology +15

4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer

C Schulman, F.M.J. Debruyne, Gerhard Förster et al. · European Urology · 2000 · 242 citations

Medicine, Oncology, Urology +12